Drug Safety Update - GOV. UKDenosumab is associated with a risk of osteonecrosis of the jaw, osteonecrosis of the external auditory canal has also been reported with denosumab. Therapeutic area: Cancer and 4 others. Published: 2. 1 June 2. Systemic cardiovascular effects including bradycardia, hypotension, and dizziness have been reported after application. Therapeutic area: Cardiovascular disease and lipidology and 1 others. Published: 2. 1 June 2. Sales restrictions introduced in 2. Therapeutic area: Ear, nose and throat. Published: 2. 1 June 2.
![]() Marsh is a global leader in insurance broking and risk management, bringing global, national, and industry- specific solutions.Use the Yellow Card Reporting Scheme to support the safety of e- cigarettes and refill containers (e- liquids). Published: 2. 1 June 2. Letters were sent about Pharmalgen (Bee Venom and Wasp Venom) Initial kits, bendamustine (Levact), and ERWINASE. Therapeutic area: Cancer and 2 others. Published: 2. 1 June 2. Alerts were issued about LIFEPAK 1. Mitroflow LX (sizes 1. ![]() ![]() EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Accu- Chek Insight insulin pumps. Therapeutic area: Cardiovascular disease and lipidology and 1 others. Published: 2. 1 June 2. We have received reports of depression and, in rare cases, suicidal thoughts in men taking finasteride 1 mg (Propecia) for male pattern hair loss. Therapeutic area: Dermatology and 2 others. Published: 2. 4 May 2. You can use our free e- learning modules to find out more about how and when to report suspected adverse drug reactions and earn CPD credits at the same time. Published: 2. 4 May 2. A summary of letters sent to healthcare professionals, including an important reminder about the withdrawal of retigabine (Trobalt) from the market. Therapeutic area: Anaesthesia and intensive care and 9 others. Published: 2. 4 May 2. Babies born to mothers who take valproate medicines (Epilim. Published: 2. 2 March 2. Prescribing information has been updated to help to minimise the risk of serious adverse reactions in patients with cardiac disease. Therapeutic area: Cardiovascular disease and lipidology and 3 others. Published: 2. 0 February 2. Healthcare professionals who use Vision can now report suspected adverse reactions to MHRA directly through their clinical software. Published: 2. 0 February 2. A summary of letters sent to relevant healthcare professionals in January 2. Therapeutic area: Cancer and 2 others. Published: 2. 0 February 2. All patients should be screened for hepatitis B before starting treatment for chronic hepatitis C with direct- acting antiviral interferon- free regimens. Therapeutic area: Immunosuppression and transplantation and 1 others. Published: 1. 9 January 2. INR should be monitored closely during treatment of chronic hepatitis C with direct- acting antivirals in patients also receiving vitamin K antagonists (eg, warfarin), because of possible changes in liver function during treatment. Therapeutic area: Anaesthesia and intensive care and 6 others. Published: 1. 4 December 2. A summary of recent letters sent to relevant healthcare professionals, to inform them of updated safety information. Therapeutic area: Cancer and 5 others. Published: 1. 4 December 2. In light of feedback, we have clarified our article on concomitant use of these medicines in heart failure. Therapeutic area: Cardiovascular disease and lipidology and 1 others. Published: 1. 3 December 2. Some patients may have exacerbation or rebound symptoms of rosacea. Therapeutic area: Dermatology. Published: 8 November 2. We are running a social media campaign to promote the reporting of suspected adverse drug reactions to the Yellow Card Scheme in support of an awareness week from 7 to 1. November 2. 01. 6. Published: 8 November 2. A summary of recent safety letters sent to relevant healthcare professionals. Therapeutic area: Cancer and 4 others. Published: 8 November 2. Prescribing information has been updated to introduce a lower recommended dose of 6. Therapeutic area: Pain management and palliation and 1 others. Published: 1. 7 October 2. A summary of letters sent to healthcare professionals in September 2. Trobalt). Therapeutic area: Neurology and 3 others. Published: 1. 7 October 2. Medicines or herbal remedies that induce CYP3. A4 enzymes reduce blood levels of levonorgestrel, which may reduce emergency contraceptive efficacy. Therapeutic area: Obstetrics, gynaecology and fertility. Published: 1. 5 September 2. Switching from posaconazole oral solution to tablets has resulted in cases of dose- related toxicity, whereas switching from tablets to oral solution has resulted in underdosing and lack of efficacy. Therapeutic area: Dentistry and 1 others. Published: 1. 5 September 2. Updated advice for healthcare professionals is available, after conclusion of a review of the safety of idelalisib, including the risk of infection. Therapeutic area: Cancer. Published: 1. 5 September 2. A summary of safety letters sent to healthcare professionals in August 2. Therapeutic area: Cancer. Published: 1. 5 September 2. Patients with pulmonary hypertension associated with idiopathic interstitial pneumonias should not be treated with riociguat in light of interim results from a recently terminated study. Therapeutic area: Cancer and 2 others. Published: 1. 0 May 2. There are new interim treatment recommendations for idelalisib for chronic lymphocytic leukaemia and follicular lymphoma in light of new findings from clinical trials outside its currently authorised drug combinations or indicated populations. Therapeutic area: Cancer and 1 others. Published: 1. 0 May 2. In April 2. 01. 6, letters were sent regarding canagliflozin (Invokana. Skills - OECDToday we rely on information and communication technologies and devices that hadn’t even been imagined just 3. The set of skills we need to participate fully in and benefit from our hyper- connected societies and increasingly knowledge- based economies has changed profoundly too. The OECD not only measures skills in student and adult populations, it also works with countries to develop skills strategies tailored to specific needs and contexts. The evidence shows that using both cognitive (literacy, numeracy) and “soft” (communicating, influencing, negotiating) skills in the workplace and maintaining them over a lifetime is strongly related to greater skills proficiency – which, in turn, is related to economic and social well- being.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2017
Categories |